Quick Summary of the Key Points
The National Health Commission has officially put an end to the controversial “blood exchange and anti-aging” practices that have been around for several years. Any use of plasma exchange or ozone therapy for anti-aging purposes in healthy individuals, or for treating sub-health conditions, is considered illegal. Ordinary people can now report such misleading and consumer-inducing activities. These “exorbitantly expensive anti-aging treatments,” which were once popular among the world’s wealthiest, essentially misappropriated the results of mouse experiments from decades ago and exploited the public by confusing legitimate medical concepts. These treatments not only have no proven anti-aging effects but also pose significant health risks and could undermine the fairness of blood usage in society. The authorities have taken decisive action to eradicate this unethical practice.
Detailed Explanation in Plain Language
1. How significant is this official ban?
The “blood exchange and anti-aging” industry had always operated in the shadows, primarily among high-end private clinics and wealthy individuals. Although everyone knew it was illegal, no one clearly defined the specific violations. Many institutions used slogans like “cutting-edge overseas technology” or “personalized anti-aging” to secretly offer these services to high-net-worth clients and make substantial profits.
This time, the National Health Commission has made the rules explicit: any service aimed at healthy individuals for anti-aging or sub-health improvement, whether using plasma exchange or ozone therapy, is illegal. It has also opened up reporting channels for the public, extending regulatory oversight to all private clinics hidden in offices and villas. The previously exploitative practices no longer have any room for maneuver.
2. Don’t be fooled by claims of “effective mouse experiments”
The entire basis for these treatments comes from experiments on mice. Initially, researchers connected the blood vessels of young and old mice, allowing them to share blood circulation, and observed that the old mice’s muscles and livers appeared younger. However, these findings have been greatly exaggerated. There is no evidence to support the effectiveness of these treatments in humans. First, the physiological differences between humans and mice are enormous; over 90% of the anti-aging methods proven effective in mice are ineffective in humans. Furthermore, scientists have discovered that simply administering saline to old mice to dilute their waste products can achieve similar effects, meaning the so-called “miraculous youth-enhancing factors” do not exist. Brian Johnson, a well-known anti-aging advocate and billionaire, personally tried these treatments but found no benefits. In 2023, he publicly announced the termination of such experiments, acknowledging their lack of efficacy.
3. Exorbitant fees and misleading marketing
The most deceptive aspect of these treatments is the misuse of terminology. Legitimate plasma exchange is used for life-saving purposes in hospitals, such as for patients with severe autoimmune diseases or poisoning. It involves filtering the patient’s blood, removing harmful substances, and replacing it with saline and albumin. In contrast, anti-aging clinics harvest plasma from young people (16–25 years old) and administer it to the elderly without any proper filtration. The FDA has issued multiple warnings about the safety risks of such practices. Fees for these treatments are exorbitant: in the U.S., the cheapest session costs $8,000, while the most expensive can reach $285,000. In China, some medical beauty clinics charge up to 1.5 million yuan for a full treatment, claiming absurd benefits like “blackening hair or curing Alzheimer’s disease,” with no evidence to support these claims.
4. This is not just a rich people’s problem
The harm from these practices affects everyone. Non-standard plasma sources can carry infectious diseases like HIV, tuberculosis, and malaria. Even if the plasma comes from “legitimate” sources, there is a risk of severe immune reactions that can be fatal. Moreover, such practices undermine the voluntary blood donation system. If selling blood becomes profitable, fewer people will donate, potentially leading to a shortage of blood for hospital surgeries and emergencies. The ethical implications are even more dire: if this trend continues, it could create a society where the wealthy use money to extend their lives at the expense of the poor, blocking opportunities for social mobility and equality.